Centre Hospitalier Universitaire d'Amiens
Amiens, Picardie, 80000, France
Location status: Recruiting
NCT Number: NCT05104619
In squamous cell carcinoma of the tongue, complete surgical resection of the tumor generally represents the primary treatment strategy. Among factors determining the disease prognostic, the surgical margins status is essential for the continued management of the patient, with or without complementary therapies. Generally, surgical margins are defined using visual and tactile elements. Unfortunately, in 15 to 30 percent of cases, they are defined as positive after histopathological examination, on average 5 to 7 days post-surgery.
Techniques have recently been developed to analyze the cancerous and non-cancerous nature of tissues, using the spectral properties of tumor cells. SpiderMass™ is an instrument equipped with a probe for tissue micro-sampling and real-time molecular profile analysis. It is thus ultimately a tool for anatomopathological decision support, for diagnosis and prognosis of the disease. Used in the operating room, SpiderMass™ could also become an innovative surgical tool to precisely define cancerous areas in situ and the margins status in intraoperative conditions.
Based on the principle of artificial intelligence, the SpiderMass™ machine must initially learn to recognize pathological tissues versus healthy. This project aims to accomplish this first phase of machine learning for squamous cell carcinoma of the tongue.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Amiens, Picardie, 80000, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In squamous cell carcinoma of the tongue, complete surgical resection of the tumor
Time frame: 1 year
Tumor cells detection in tongue tumor with SpiderMass technique
Contact information is provided by the study sponsor or research team.
Centre Hospitalier Universitaire, Amiens
Other
Prospective Analysis of Tumor Tissues From the Oral Cavity by SpiderMassTM Spectroscopy
Acronym: SpecTum
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00201383
Carcinoma, Carcinoma, Squamous Cell
Taipei, Taiwan
View Trial DetailsNCT00201279
Carcinoma, Carcinoma, Squamous Cell
Taipei, Taiwan
View Trial DetailsNCT07285044
Adenocarcinoma, Adnexal Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT06047379
Adenocarcinoma, Astrocytoma
Beverly Hills, California, United States
View Trial Details